FDA Approved: ABIRATERONE — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved BluePoint Laboratories' original application for ABIRATERONE acetate as a generic version for prostate cancer (metastatic castration-resistant pros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)

Snippet

ORIG AP for ABIRATERONE (ABIRATERONE ACETATE)